mifepristone has been researched along with Salivary Gland Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
El-Naggar, AK; Ferrarotto, R; Lin, SH; Mitani, Y; Pytynia, KB | 1 |
Bai, H; Cao, Y; Du, L; Gao, L; Li, J; Liu, H; Lu, L; Lu, SL; Said, S; Serkova, N; Song, J; Wang, XJ; Wei, M; Xiao, J | 1 |
2 other study(ies) available for mifepristone and Salivary Gland Neoplasms
Article | Year |
---|---|
Reciprocal and Autonomous Glucocorticoid and Androgen Receptor Activation in Salivary Duct Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Benzamides; Biomarkers, Tumor; Carcinoma, Ductal; Cell Line, Tumor; Cell Proliferation; Female; Hormone Antagonists; Humans; Male; Middle Aged; Mifepristone; Nitriles; Phenylthiohydantoin; Receptors, Androgen; Receptors, Glucocorticoid; Salivary Gland Neoplasms | 2020 |
Cooperation Between Pten and Smad4 in Murine Salivary Gland Tumor Formation and Progression.
Topics: Animals; Carcinoma, Adenoid Cystic; Disease Progression; Humans; Mice; Mice, Inbred C57BL; Mifepristone; Phosphatidylinositol 3-Kinases; PTEN Phosphohydrolase; Salivary Gland Neoplasms; Salivary Glands; Signal Transduction; Smad4 Protein; TOR Serine-Threonine Kinases; Transforming Growth Factor beta | 2018 |